Enzymatic vs. Non-Enzymatic Sensor Chemistry | DSR
Technology & Innovation

Enzymatic vs. Non-Enzymatic Sensor Chemistry

Diabetic test strips turn glucose into an electrical signal, and mainstream strips rely on Enzymatic Sensors built on Glucose Oxidase (GOx) or Glucose Dehydrogenase (GDH). GOx is selective for glucose but can be nudged by oxygen in the blood. GDH doesn't use oxygen, but the GDH-PQQ strips of the 2000s also reacted with maltose and other sugars, and the FDA linked that interference to deaths in 2009. GDH-FAD and GDH-NAD strips avoid that problem, while glucose oxidase strips and a modified GDH-PQQ strip are still sold as of October 2026.

Non-Enzymatic Sensors oxidize glucose directly on metals such as gold and platinum or on nanomaterials. They promise better stability and lower cost than enzymes, but in research reviews they still struggle with selectivity, because other sugars and blood components react at the same electrode.

Diabetic Supply Rescue Editorial Team
3 min read
Last updated: October 09, 2026
Advanced
7 glossary terms
10 citations

Enzymatic vs Non-Enzymatic Sensor Chemistry

Mainstream home test strips run on enzymes. A strip holds either glucose oxidase (GOx) or glucose dehydrogenase (GDH), plus a redox mediator, a chemical that carries electrons from the enzyme to the electrode so the meter can measure a current [3].

GOx is selective for glucose [6], but it has a weak spot. Oxygen from red blood cells can compete with the mediator for the electrons glucose gives up, so the oxygen level of the sample can shift the result (sometimes called the oxygen effect) [3]. GDH doesn't react with oxygen at all [3]. Its versions are named for the cofactor, the helper molecule that accepts electrons: PQQ (pyrroloquinoline quinone), FAD (flavin adenine dinucleotide) or NAD (nicotinamide adenine dinucleotide) [3].

The GDH-PQQ strips of the 2000s couldn't tell glucose from some other sugars. In August 2009 the FDA warned that maltose, xylose and galactose make these strips read falsely high, and it counted 13 deaths from 1997 to 2009 tied to that interference, all in healthcare facilities [1]. Ten of those patients were on Extraneal, an icodextrin peritoneal dialysis solution that the body breaks down mainly into maltose [1] [3].

The same notice said glucose oxidase, GDH-NAD and GDH-FAD strips are not affected by these sugars [1]. Many current strips use one of those GDH types: Accu-Chek Guide strips use FAD-GDH [7], and FreeStyle Precision Neo strips use GDH-NAD [8].

Older chemistries are still on the shelf, though. Accu-Chek Aviva Plus strips, cleared by the FDA in 2011, use a modified ("mutant") GDH-PQQ enzyme [4], and the OneTouch Ultra 2 user guide lists its assay as a glucose oxidase biosensor that runs on OneTouch Ultra strips [5]. As of October 2026, Roche and LifeScan both still list these strips [9] [10]. Here's what surprised us: even the modified enzyme has a known sugar interference, since the FDA summary for Aviva Plus says galactose above 15 mg/dL causes overestimation [4]. If you receive a treatment that contains non-glucose sugars, which strip to use is a decision for your care team.

Non-Enzymatic Sensors

Non-enzymatic sensors drop the enzyme and oxidize glucose directly on the electrode [6]. Research designs use noble metals such as platinum and gold or their alloys [2]. Others use metal oxides, and many are shaped into nanostructures that expose more electrode surface to glucose [2] [6]. The pitch is durability and price. Enzymes lose activity over time, while metal electrodes hold up, and one 2021 review calls direct sensing cheap and rapid [6].

Selectivity is where they fall short. Several sugars oxidize on these surfaces in the same voltage range as glucose, and chloride ions in blood can foul the electrode [6]. At higher voltages, compounds such as ascorbic acid and uric acid add current of their own [6]. Many designs also work best in strongly alkaline solutions [6], which a drop of blood is not. The 2018 and 2021 reviews we read still treat commercial use as a hurdle to clear rather than a finished product [2] [6].

References

  1. FDA Public Health Notification: Potentially Fatal Errors with GDH-PQQ Glucose Monitoring Technology (archived copy)Source
  2. Recent advances in electrochemical non-enzymatic glucose sensors - A review (Hwang DW, Lee S, Seo M, Chung TD. Anal Chim Acta 2018;1033:1-34)Source
  3. Glucose Biosensors: An Overview of Use in Clinical Practice (Yoo EH, Lee SY. Sensors 2010;10(5):4558-4576)Source
  4. FDA 510(k) Decision Summary K101299: ACCU-CHEK Aviva Plus Blood Glucose Monitoring SystemSource
  5. OneTouch Ultra 2 Blood Glucose Monitoring System User Guide (LifeScan, AW 06650010A, rev. 02/2023)Source
  6. Recent Advances in Enzymatic and Non-Enzymatic Electrochemical Glucose Sensing (Hassan MH, et al. Sensors 2021;21(14):4672)Source
  7. FDA 510(k) Decision Summary K160944: ACCU-CHEK Guide Blood Glucose Monitoring SystemSource
  8. FDA 510(k) Decision Summary K171941: FreeStyle Precision Neo Blood Glucose Test StripsSource
  9. Accu-Chek: Test strips FAQ (Roche Diabetes Care)Source
  10. OneTouch Ultra Test Strips product page (LifeScan)Source

Was this article helpful?

Explore More Topics

Continue your research with related categories